Technical Analysis for ERYP - Erytech Pharma S.A.

Grade Last Price % Change Price Change
grade C 8.0 3.36% 0.26
ERYP closed up 3.36 percent on Friday, January 18, 2019, on 3.24 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ERYP trend table...

Date Alert Name Type % Chg
Jan 18 Volume Surge Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Gapped Up Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 MACD Bullish Centerline Cross Bullish 3.36%
Jan 17 Narrow Range Bar Range Contraction 3.36%
Jan 17 Wide Bands Range Expansion 3.36%
Jan 17 Overbought Stochastic Strength 3.36%
Jan 17 Gapped Down Weakness 3.36%

Older signals for ERYP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.
Is ERYP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.56
52 Week Low 5.45
Average Volume 4,476
200-Day Moving Average 13.6648
50-Day Moving Average 7.2262
20-Day Moving Average 6.958
10-Day Moving Average 7.273
Average True Range 0.4727
ADX 16.1
+DI 49.9033
-DI 23.7159
Chandelier Exit (Long, 3 ATRs ) 6.951899999999999
Chandelier Exit (Short, 3 ATRs ) 6.8681
Upper Bollinger Band 8.219
Lower Bollinger Band 5.697
Percent B (%b) 0.91
BandWidth 36.246048
MACD Line 0.112
MACD Signal Line -0.0802
MACD Histogram 0.1922
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.56
Resistance 3 (R3) 8.62 8.49 8.46
Resistance 2 (R2) 8.49 8.35 8.46 8.43
Resistance 1 (R1) 8.25 8.26 8.19 8.19 8.40
Pivot Point 8.12 8.12 8.09 8.09 8.12
Support 1 (S1) 7.88 7.98 7.82 7.82 7.60
Support 2 (S2) 7.75 7.89 7.72 7.57
Support 3 (S3) 7.51 7.75 7.54
Support 4 (S4) 7.45